APA

Lin C., von der Thüsen J., Daalhuisen J., ten Brink M., Crestani B., van der Poll T., Borensztajn K. & Spek C. A. (20160607). Pharmacological Targeting of Protease-Activated Receptor 2 Affords Protection from Bleomycin-Induced Pulmonary Fibrosis. : Molecular medicine (Cambridge, Mass.).

Chicago

Lin Cong, von der Thüsen Jan, Daalhuisen Joost, ten Brink Marieke, Crestani Bruno, van der Poll Tom, Borensztajn Keren and Spek C Arnold. 20160607. Pharmacological Targeting of Protease-Activated Receptor 2 Affords Protection from Bleomycin-Induced Pulmonary Fibrosis. : Molecular medicine (Cambridge, Mass.).

Harvard

Lin C., von der Thüsen J., Daalhuisen J., ten Brink M., Crestani B., van der Poll T., Borensztajn K. and Spek C. A. (20160607). Pharmacological Targeting of Protease-Activated Receptor 2 Affords Protection from Bleomycin-Induced Pulmonary Fibrosis. : Molecular medicine (Cambridge, Mass.).

MLA

Lin Cong, von der Thüsen Jan, Daalhuisen Joost, ten Brink Marieke, Crestani Bruno, van der Poll Tom, Borensztajn Keren and Spek C Arnold. Pharmacological Targeting of Protease-Activated Receptor 2 Affords Protection from Bleomycin-Induced Pulmonary Fibrosis. : Molecular medicine (Cambridge, Mass.). 20160607.